- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
10
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
10 companies
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$946.8m
Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$1.69
7D
9.0%
1Y
-6.6%
Hangzhou Jiuyuan Genetic Biopharmaceutical
Market Cap: HK$1.5b
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
2566
HK$6.06
7D
4.8%
1Y
n/a
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.15
7D
4.5%
1Y
-4.2%
Jacobson Pharma
Market Cap: HK$2.5b
Through its subsidiaries, develops, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.25
7D
10.6%
1Y
115.5%
TOT BIOPHARM International
Market Cap: HK$1.4b
An investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in China.
1875
HK$1.78
7D
11.3%
1Y
17.9%
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.00
7D
22.7%
1Y
117.4%
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in the People’s Republic of China, Hong Kong, and internationally.
1061
HK$4.45
7D
12.1%
1Y
97.8%
Consun Pharmaceutical Group
Market Cap: HK$8.0b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.63
7D
12.4%
1Y
75.7%
Alphamab Oncology
Market Cap: HK$6.7b
A clinical stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of oncology biologics.
9966
HK$6.98
7D
15.6%
1Y
63.8%
China Shineway Pharmaceutical Group
Market Cap: HK$5.8b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong.
2877
HK$7.74
7D
4.5%
1Y
-17.5%